Indian pharma associations push for streamlined drug pricing regulations

In a bid to accelerate the introduction of new medicines to the Indian market, pharmaceutical industry associations have proposed sweeping changes to the drug pricing regulations.

In a formal request to the Department of Pharmaceuticals, associations have outlined several procedural simplifications aimed at reducing bureaucratic hurdles.

The proposed reforms' key recommendations include the reduction of redundant documentation and the introduction of a fast-track approval process for drugs that address critical health needs.